97 related articles for article (PubMed ID: 22245140)
1. The BRCA1 alternative splicing variant Δ14-15 with an in-frame deletion of part of the regulatory serine-containing domain (SCD) impairs the DNA repair capacity in MCF-7 cells.
Sevcik J; Falk M; Kleiblova P; Lhota F; Stefancikova L; Janatova M; Weiterova L; Lukasova E; Kozubek S; Pohlreich P; Kleibl Z
Cell Signal; 2012 May; 24(5):1023-30. PubMed ID: 22245140
[TBL] [Abstract][Full Text] [Related]
2. Expression of human BRCA1Δ17-19 alternative splicing variant with a truncated BRCT domain in MCF-7 cells results in impaired assembly of DNA repair complexes and aberrant DNA damage response.
Sevcik J; Falk M; Macurek L; Kleiblova P; Lhota F; Hojny J; Stefancikova L; Janatova M; Bartek J; Stribrna J; Hodny Z; Jezkova L; Pohlreich P; Kleibl Z
Cell Signal; 2013 May; 25(5):1186-93. PubMed ID: 23416467
[TBL] [Abstract][Full Text] [Related]
3. Identification of sequences that target BRCA1 to nuclear foci following alkylative DNA damage.
Au WW; Henderson BR
Cell Signal; 2007 Sep; 19(9):1879-92. PubMed ID: 17531442
[TBL] [Abstract][Full Text] [Related]
4. Checkpoint kinase 2-mediated phosphorylation of BRCA1 regulates the fidelity of nonhomologous end-joining.
Zhuang J; Zhang J; Willers H; Wang H; Chung JH; van Gent DC; Hallahan DE; Powell SN; Xia F
Cancer Res; 2006 Feb; 66(3):1401-8. PubMed ID: 16452195
[TBL] [Abstract][Full Text] [Related]
5. BRCA1-mediated repression of mutagenic end-joining of DNA double-strand breaks requires complex formation with BACH1.
Dohrn L; Salles D; Siehler SY; Kaufmann J; Wiesmüller L
Biochem J; 2012 Feb; 441(3):919-26. PubMed ID: 22032289
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer risk and the DNA double-strand break end-joining capacity of nonhomologous end-joining genes are affected by BRCA1.
Bau DT; Fu YP; Chen ST; Cheng TC; Yu JC; Wu PE; Shen CY
Cancer Res; 2004 Jul; 64(14):5013-9. PubMed ID: 15256476
[TBL] [Abstract][Full Text] [Related]
7. Cloning and characterization of a new BRCA1 variant: A role for BRCT domains in apoptosis.
Gu M; Li H; Shen C; Wu L; Liu W; Miao L; Zheng C
Cancer Lett; 2010 Sep; 295(2):205-13. PubMed ID: 20356671
[TBL] [Abstract][Full Text] [Related]
8. BRCA1 promotes induction of ssDNA by ionizing radiation.
Schlegel BP; Jodelka FM; Nunez R
Cancer Res; 2006 May; 66(10):5181-9. PubMed ID: 16707442
[TBL] [Abstract][Full Text] [Related]
9. The BRCA1 c.5434C->G (p.Pro1812Ala) variant induces a deleterious exon 23 skipping by affecting exonic splicing regulatory elements.
Gaildrat P; Krieger S; Théry JC; Killian A; Rousselin A; Berthet P; Frébourg T; Hardouin A; Martins A; Tosi M
J Med Genet; 2010 Jun; 47(6):398-403. PubMed ID: 20522429
[TBL] [Abstract][Full Text] [Related]
10. Ataxia telangiectasia mutated and checkpoint kinase 2 regulate BRCA1 to promote the fidelity of DNA end-joining.
Wang HC; Chou WC; Shieh SY; Shen CY
Cancer Res; 2006 Feb; 66(3):1391-400. PubMed ID: 16452194
[TBL] [Abstract][Full Text] [Related]
11. Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-delta11b.
Wilson CA; Payton MN; Elliott GS; Buaas FW; Cajulis EE; Grosshans D; Ramos L; Reese DM; Slamon DJ; Calzone FJ
Oncogene; 1997 Jan; 14(1):1-16. PubMed ID: 9010228
[TBL] [Abstract][Full Text] [Related]
12. BRCA1 requirement for the fidelity of plasmid DNA double-strand break repair in cultured breast epithelial cells.
Thompson EG; Fares H; Dixon K
Environ Mol Mutagen; 2012 Jan; 53(1):32-43. PubMed ID: 22170030
[TBL] [Abstract][Full Text] [Related]
13. Collective evidence supports neutrality of BRCA1 V1687I, a novel sequence variant in the conserved THV motif of the first BRCT repeat.
Cortesi L; De Nicolo A; Medici V; Marino M; Turchetti D; Pradella LM; Rossi G; Parisini E; Federico M
Breast Cancer Res Treat; 2012 Jul; 134(1):435-41. PubMed ID: 22527099
[TBL] [Abstract][Full Text] [Related]
14. DNA double-strand break repair activities in mammary epithelial cells--influence of endogenous p53 variants.
Keimling M; Wiesmüller L
Carcinogenesis; 2009 Jul; 30(7):1260-8. PubMed ID: 19429664
[TBL] [Abstract][Full Text] [Related]
15. The role of the BRCA1 tumor suppressor in DNA double-strand break repair.
Zhang J; Powell SN
Mol Cancer Res; 2005 Oct; 3(10):531-9. PubMed ID: 16254187
[TBL] [Abstract][Full Text] [Related]
16. Ecdysteroid-responsive genes, RXR and E75, in the tropical land crab, Gecarcinus lateralis: differential tissue expression of multiple RXR isoforms generated at three alternative splicing sites in the hinge and ligand-binding domains.
Kim HW; Lee SG; Mykles DL
Mol Cell Endocrinol; 2005 Oct; 242(1-2):80-95. PubMed ID: 16150535
[TBL] [Abstract][Full Text] [Related]
17. hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response.
Lee JS; Collins KM; Brown AL; Lee CH; Chung JH
Nature; 2000 Mar; 404(6774):201-4. PubMed ID: 10724175
[TBL] [Abstract][Full Text] [Related]
18. Transactivation of the p21 promoter by BRCA1 splice variants in mammary epithelial cells: evidence for both common and distinct activities of wildtype and mutant forms.
Lu M; Arrick BA
Oncogene; 2000 Dec; 19(54):6351-60. PubMed ID: 11175350
[TBL] [Abstract][Full Text] [Related]
19. Retroviral transduction of splice variant Brca1-Delta11 or mutant Brca1-W1777Stop causes mouse epithelial mammary atypical duct hyperplasia.
Bachelier R; Vincent A; Mathevet P; Magdinier F; Lenoir GM; Frappart L
Virchows Arch; 2002 Mar; 440(3):261-6. PubMed ID: 11889595
[TBL] [Abstract][Full Text] [Related]
20. Expression profiles of BRCA1 splice variants in asynchronous and in G1/S synchronized tumor cell lines.
Orban TI; Olah E
Biochem Biophys Res Commun; 2001 Jan; 280(1):32-8. PubMed ID: 11162473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]